412 related articles for article (PubMed ID: 23783557)
1. The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses.
Soliman GA
Nutrients; 2013 Jun; 5(6):2231-57. PubMed ID: 23783557
[TBL] [Abstract][Full Text] [Related]
2. Mammalian target of rapamycin and tuberous sclerosis complex.
Wataya-Kaneda M
J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
[TBL] [Abstract][Full Text] [Related]
3. mTOR Signaling pathway as a master regulator of memory CD8
Rostamzadeh D; Yousefi M; Haghshenas MR; Ahmadi M; Dolati S; Babaloo Z
J Cell Physiol; 2019 Aug; 234(8):12353-12368. PubMed ID: 30710341
[TBL] [Abstract][Full Text] [Related]
4. MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.
Jones RG; Pearce EJ
Immunity; 2017 May; 46(5):730-742. PubMed ID: 28514674
[TBL] [Abstract][Full Text] [Related]
5. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.
Yang H; Wang X; Zhang Y; Liu H; Liao J; Shao K; Chu Y; Liu G
J Cell Physiol; 2014 Jan; 229(1):17-26. PubMed ID: 23804073
[TBL] [Abstract][Full Text] [Related]
6. Regulation of immune responses by mTOR.
Powell JD; Pollizzi KN; Heikamp EB; Horton MR
Annu Rev Immunol; 2012; 30():39-68. PubMed ID: 22136167
[TBL] [Abstract][Full Text] [Related]
7. mTOR in aging, metabolism, and cancer.
Cornu M; Albert V; Hall MN
Curr Opin Genet Dev; 2013 Feb; 23(1):53-62. PubMed ID: 23317514
[TBL] [Abstract][Full Text] [Related]
8. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
9. New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs).
Feldman ME; Shokat KM
Curr Top Microbiol Immunol; 2010; 347():241-62. PubMed ID: 20549474
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin passes the torch: a new generation of mTOR inhibitors.
Benjamin D; Colombi M; Moroni C; Hall MN
Nat Rev Drug Discov; 2011 Oct; 10(11):868-80. PubMed ID: 22037041
[TBL] [Abstract][Full Text] [Related]
11. Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells.
Sunayama J; Sato A; Matsuda K; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
Neuro Oncol; 2010 Dec; 12(12):1205-19. PubMed ID: 20861085
[TBL] [Abstract][Full Text] [Related]
12. The Role of mTOR Signaling as a Therapeutic Target in Cancer.
Popova NV; Jücker M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572326
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular effects of the mTOR inhibitor everolimus.
Saran U; Foti M; Dufour JF
Clin Sci (Lond); 2015 Nov; 129(10):895-914. PubMed ID: 26330617
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of rapamycin-induced cell death.
Galluzzi L; Morselli E; Kepp O; Vitale I; Younes AB; Maiuri MC; Kroemer G
Methods Mol Biol; 2012; 821():125-69. PubMed ID: 22125064
[TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin: a central node of complex signaling cascades.
Dobashi Y; Watanabe Y; Miwa C; Suzuki S; Koyama S
Int J Clin Exp Pathol; 2011 Jun; 4(5):476-95. PubMed ID: 21738819
[TBL] [Abstract][Full Text] [Related]
16. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease.
Panwar V; Singh A; Bhatt M; Tonk RK; Azizov S; Raza AS; Sengupta S; Kumar D; Garg M
Signal Transduct Target Ther; 2023 Oct; 8(1):375. PubMed ID: 37779156
[TBL] [Abstract][Full Text] [Related]
17. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.
Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin inhibits transforming growth factor beta 1 induced myofibroblast differentiation via the phosphorylated-phosphatidylinositol 3-kinase mammalian target of rapamycin signal pathways in nasal polyp-derived fibroblasts.
Ko DY; Shin JM; Um JY; Kang B; Park IH; Lee HM
Am J Rhinol Allergy; 2016 Nov; 30(6):211-217. PubMed ID: 28124643
[TBL] [Abstract][Full Text] [Related]
19. Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention.
O'Shea AE; Valdera FA; Ensley D; Smolinsky TR; Cindass JL; Kemp Bohan PM; Hickerson AT; Carpenter EL; McCarthy PM; Adams AM; Vreeland TJ; Clifton GT; Peoples GE
Clin Immunol; 2022 Dec; 245():109095. PubMed ID: 35973640
[TBL] [Abstract][Full Text] [Related]
20. mTORC1 and mTORC2 as regulators of cell metabolism in immunity.
Linke M; Fritsch SD; Sukhbaatar N; Hengstschläger M; Weichhart T
FEBS Lett; 2017 Oct; 591(19):3089-3103. PubMed ID: 28600802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
